| Drug Name |
Nizatidine |
| Drug ID |
BADD_D01582 |
| Description |
A histamine H2 receptor antagonist with low toxicity that inhibits gastric acid secretion. The drug is used for the treatment of duodenal ulcers. |
| Indications and Usage |
For the treatment of acid-reflux disorders (GERD), peptic ulcer disease, active benign gastric ulcer, and active duodenal ulcer. |
| Marketing Status |
Prescription; OTC; Discontinued |
| ATC Code |
A02BA04 |
| DrugBank ID |
DB00585
|
| KEGG ID |
D00440
|
| MeSH ID |
D016567
|
| PubChem ID |
3033637
|
| TTD Drug ID |
D0Q9DK
|
| NDC Product Code |
55111-310; 55111-311; 60846-301; 68071-1633; 63629-2769; 68462-425; 71335-0086; 63187-249; 0591-3137; 68071-5043; 65162-659; 0591-3138; 55111-011; 72643-018; 68462-426 |
| Synonyms |
Nizatidine | N-(2-(((2-((Dimethylamino)methyl)-4-thiazolyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine | LY-139037 | LY 139037 | LY139037 | Axid |
